The Centers for Disease Control and Prevention profiles the typical sleep aid user, and finds that eight hours does not mean consumers are sleeping without help.
With its recent actions on sleep aids and allergy medications, the FDA is demonstrating growing concern about the effects of prescription drugs on driving. One CRO is fielding a fleet of driving simulators to help manufacturers salve the agency's worries.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.